Forte T M, Bielicki J K, Goth-Goldstein R, Selmek J, McCall M R
Life Sciences Division, Lawrence Berkeley Laboratory, University of California, Berkeley 94720.
J Lipid Res. 1995 Jan;36(1):148-57.
Studies were carried out to determine whether apolipoprotein (apo) A-II, like apoA-I, can recruit phospholipid and cholesterol from cell membranes, thereby forming nascent apoA-II-specific HDL. ApoA-II and apoA-I were purified from plasma and each was incubated with CHO cells at a concentration of 10 micrograms/ml. Lipid-containing complexes were isolated from the medium in both cases; the composition of the apoA-II- and apoA-I-specific complexes were similar where percent protein, phospholipid, and cholesterol were 35 +/- 3, 38 +/- 2, and 25 +/- 1 for apoA-II, respectively, and 40 +/- 2, 35 +/- 1, and 24 +/- 2 for apoA-I, respectively. On a per mole of apolipoprotein basis, apoA-I recruited significantly more phospholipid and cholesterol than dimeric apoA-II suggesting that apoA-I with its greater number of alpha helices binds more lipid. By electron microscopy, nascent apoA-II- and apoA-I-specific particles were predominantly discoidal in morphology. ApoA-II complexes were unique in their nondenaturing polyacrylamide gradient gel size distribution as six distinct populations of particles with diameters of 8.1, 9.3, 10.4, 11.8, 13.1, and 14.6 nm were routinely noted, compared with apoA-I which formed only three major populations with diameters of 7.3, 9.2, and 11.0 nm. Nascent apoA-I complexes incubated with purified lecithin:cholesterol acyltransferase (LCAT) were transformed into predominantly 8.4 nm particles. The latter is similar in size to plasma HDL3a, LpA-I particles, suggesting that extracellularly assembled apoA-I-lipid complexes can directly give rise to a major plasma LpA-I subpopulation upon interaction with LCAT. Unlike apoA-I, apoA-II-lipid complexes could not serve as substrates for LCAT and did not undergo transformation. This study also demonstrates, for the first time, that apoA-II and apoA-I show a preference in phospholipid recruitment from membranes. Although phosphatidylcholine is the major phospholipid removed by both apolipoproteins, apoA-II preferentially recruits phosphatidylethanolamine (PE) as its second most abundant phospholipid while apoA-I recruits sphingomyelin. As PE is usually associated with the inner leaflet of the membrane, it is likely that dimeric apoA-II, compared with apoA-I, can penetrate farther into the membrane and extract PE. This ability of apoA-II to insert more deeply into the lipid milieu may explain the known ability of apoA-II to resist dissociation from the mature HDL particle.
开展了多项研究以确定载脂蛋白(apo)A-II是否能像apoA-I一样,从细胞膜募集磷脂和胆固醇,从而形成新生的apoA-II特异性高密度脂蛋白(HDL)。从血浆中纯化apoA-II和apoA-I,并将它们分别以10微克/毫升的浓度与中国仓鼠卵巢(CHO)细胞一起孵育。在这两种情况下,均从培养基中分离出含脂质的复合物;apoA-II特异性复合物和apoA-I特异性复合物的组成相似,其中apoA-II的蛋白质、磷脂和胆固醇百分比分别为35±3%、38±2%和25±1%,apoA-I的分别为40±2%、35±1%和24±2%。以每摩尔载脂蛋白计,apoA-I募集的磷脂和胆固醇比二聚体apoA-II显著更多,这表明具有更多α螺旋的apoA-I结合的脂质更多。通过电子显微镜观察,新生的apoA-II特异性颗粒和apoA-I特异性颗粒在形态上主要呈盘状。apoA-II复合物在非变性聚丙烯酰胺梯度凝胶大小分布方面独具特色,通常可观察到六个不同的颗粒群体,其直径分别为8.1、9.3、10.4、11.8、13.1和14.6纳米,而apoA-I仅形成三个主要群体,直径分别为7.3、9.2和11.0纳米。与纯化的卵磷脂:胆固醇酰基转移酶(LCAT)一起孵育的新生apoA-I复合物转变为主要直径为8.4纳米的颗粒。后者的大小与血浆HDL3a、LpA-I颗粒相似,这表明细胞外组装的apoA-I-脂质复合物在与LCAT相互作用后可直接产生主要的血浆LpA-I亚群。与apoA-I不同,apoA-II-脂质复合物不能作为LCAT的底物,也不会发生转变。本研究还首次证明,apoA-II和apoA-I在从膜中募集磷脂方面存在偏好。虽然磷脂酰胆碱是两种载脂蛋白去除的主要磷脂,但apoA-II优先募集磷脂酰乙醇胺(PE)作为其第二丰富的磷脂,而apoA-I募集鞘磷脂。由于PE通常与膜的内小叶相关联,与apoA-I相比,二聚体apoA-II可能更深入地穿透膜并提取PE。apoA-II这种更深入插入脂质环境的能力可能解释了已知的apoA-II抵抗从成熟HDL颗粒解离的能力。